Insider Transactions in Q2 2022 at Cyclo Therapeutics, Inc. (CYTH)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 20
2022
|
Francis Patrick Ostronic Director |
BUY
Open market or private purchase
|
Direct |
5,000
+1.74%
|
$10,000
$2.02 P/Share
|
|
May 16
2022
|
Jeffrey Tate Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+8.53%
|
$6,000
$2.12 P/Share
|
|
May 03
2022
|
Randall M. Toig Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,267
+4.46%
|
-
|
|
May 03
2022
|
Markus Sieger Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,223
+4.69%
|
-
|
|
May 03
2022
|
Francis Patrick Ostronic Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,249
+3.78%
|
-
|
|
Apr 29
2022
|
Jeffrey Tate Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
1,365
+2.29%
|
$2,730
$2.71 P/Share
|
|
Apr 28
2022
|
Jeffrey Tate Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
635
+2.23%
|
$1,270
$2.5 P/Share
|
|
Apr 06
2022
|
Francis Patrick Ostronic Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+3.75%
|
$10,000
$2.9 P/Share
|